OXYGENTA PHARMACEUTICAL
Back to Income Statement
|
OXYGENTA PHARMACEUTICAL Last 5 Year Revenue History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹40 Cr | ₹31 Cr | ₹6,052,481 Cr | ₹52 Cr | ₹14 Cr |
What is the latest Revenue of OXYGENTA PHARMACEUTICAL ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹40 Cr |
| Mar2024 | ₹31 Cr |
| Mar2023 | ₹6,052,481 Cr |
| Mar2022 | ₹52 Cr |
| Mar2021 | ₹14 Cr |
How is Revenue of OXYGENTA PHARMACEUTICAL Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹40 Cr | 27.93 | |
| Mar2024 | ₹31 Cr | -100.00 | |
| Mar2023 | ₹6,052,481 Cr | 11,633,245.46 | |
| Mar2022 | ₹52 Cr | 279.32 | |
| Mar2021 | ₹14 Cr | - | |
Compare Revenue of peers of OXYGENTA PHARMACEUTICAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| OXYGENTA PHARMACEUTICAL | ₹172.6 Cr | -3.8% | -7.4% | -38.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,837.0 Cr | 1% | 3.8% | 0.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,175.0 Cr | -1.7% | -4.1% | 3.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,394.0 Cr | -0% | -3% | 33.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,999.0 Cr | -1.3% | -1.3% | 8.6% | Stock Analytics | |
| CIPLA | ₹100,379.0 Cr | -1.1% | -6.3% | -18.3% | Stock Analytics | |
OXYGENTA PHARMACEUTICAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| OXYGENTA PHARMACEUTICAL | -3.8% |
-7.4% |
-38.5% |
| SENSEX | -0.8% |
-11.7% |
-3.6% |
You may also like the below Video Courses